Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Hansen

Showing results (181-190 of 483) with videos related to

Pageof 49
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Phenylcyanoguanidines as inhibitors of glucose-induced insulin secretion from beta cellsT M Tagmose, J P Mogensen, P C Agerholm, et al.
Journal of Thrombosis and Haemostasis : JTH|July 31, 2008
No evidence for the presence of tissue factor in high-purity preparations of immunologically isolated eosinophilsM A Sovershaev, K F Lind, H Devold, et al.
Thrombosis and Haemostasis|March 1, 2013
Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø StudyE Brodin, G Lerstad, G Grimnes, et al.
Ugeskrift for Laeger|July 24, 1989
[A group of homosexuals change their sex habits after information about AIDS. A questionnaire survey]J Bøttzauw, K Hermansen, P Tauris, et al.
Ugeskrift for Laeger|July 24, 1989
[Knowledge of AIDS and of transmission risks of HIV infection in a group of homosexual people. A questionnaire study]J Bøttzauw, K Hermansen, P Tauris, et al.
Journal of Thrombosis and Haemostasis : JTH|May 22, 2016
C-reactive protein, obesity, and the risk of arterial and venous thrombosisL D Horvei, G Grimnes, K Hindberg, et al.
Journal of Thrombosis and Haemostasis : JTH|November 3, 2017
Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø studyL D Horvei, S K Braekkan, E N Smith, et al.
Journal of Thrombosis and Haemostasis : JTH|January 3, 2014
Hyperglycemia, assessed according to HbA1c , and future risk of venous thromboembolism: the Tromsø studyG Lerstad, E E Brodin, K F Enga, et al.
Thrombosis Research|July 27, 2010
Bone morphogenetic protein -7 increases thrombogenicity of lipid-rich atherosclerotic plaques via activation of tissue factorM A Sovershaev, E M Egorina, V Y Bogdanov, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1989
LHRH analogue as a depot preparation (Zoladex) in the treatment of advanced carcinoma of the prostate followed by orchiectomy as a second line therapy--a phase II studyP Iversen, C Rose, J G Stage, et al.
Pageof 49

Showing results (181-190 of 483) with videos related to

Sort By:
Pageof 49
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Phenylcyanoguanidines as inhibitors of glucose-induced insulin secretion from beta cellsT M Tagmose, J P Mogensen, P C Agerholm, et al.
Journal of Thrombosis and Haemostasis : JTH|July 31, 2008
No evidence for the presence of tissue factor in high-purity preparations of immunologically isolated eosinophilsM A Sovershaev, K F Lind, H Devold, et al.
Thrombosis and Haemostasis|March 1, 2013
Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø StudyE Brodin, G Lerstad, G Grimnes, et al.
Ugeskrift for Laeger|July 24, 1989
[A group of homosexuals change their sex habits after information about AIDS. A questionnaire survey]J Bøttzauw, K Hermansen, P Tauris, et al.
Ugeskrift for Laeger|July 24, 1989
[Knowledge of AIDS and of transmission risks of HIV infection in a group of homosexual people. A questionnaire study]J Bøttzauw, K Hermansen, P Tauris, et al.
Journal of Thrombosis and Haemostasis : JTH|May 22, 2016
C-reactive protein, obesity, and the risk of arterial and venous thrombosisL D Horvei, G Grimnes, K Hindberg, et al.
Journal of Thrombosis and Haemostasis : JTH|November 3, 2017
Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø studyL D Horvei, S K Braekkan, E N Smith, et al.
Journal of Thrombosis and Haemostasis : JTH|January 3, 2014
Hyperglycemia, assessed according to HbA1c , and future risk of venous thromboembolism: the Tromsø studyG Lerstad, E E Brodin, K F Enga, et al.
Thrombosis Research|July 27, 2010
Bone morphogenetic protein -7 increases thrombogenicity of lipid-rich atherosclerotic plaques via activation of tissue factorM A Sovershaev, E M Egorina, V Y Bogdanov, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1989
LHRH analogue as a depot preparation (Zoladex) in the treatment of advanced carcinoma of the prostate followed by orchiectomy as a second line therapy--a phase II studyP Iversen, C Rose, J G Stage, et al.
Pageof 49